The Near Infra Red Absorbing Material Market is expected to reach USD 263.7 million in 2022, growing at a CAGR of 12.02% Forecast by 2030.

Ameya Sapphire 57, developed by the esteemed Ameya Group, is a landmark commercial project situated in the heart of Sector 57, Gurgaon. Spanning 1.6 acres, this RERA-approved development offers 237 meticulously designed units, encompassing double-height showrooms, retail shops, a state-of-the-art multiplex, a diverse food court, and a dedicated Medizone for healthcare services. Strategically positioned near Golf Course Extension Road, Sohna Road, and NH-8, Ameya Sapphire 57 ensures seamless connectivity to major hubs like MG Road, DLF Cyber City, and the Indira Gandhi International Airport. Its proximity to affluent residential neighborhoods such as Nirvana Country, Orchid Island, and Sushant Lok II & III guarantees a steady footfall, making it an ideal location for businesses aiming for high visibility and growth.


Ameya Sapphire 57
Commercial Space Gurgaon

Email id -- info@trueassetconsultancy.com
phone no. -- 8750007475

M3M Route 65 is a cutting-edge commercial and retail project located in Sector 65, Gurugram, on the bustling Golf Course Extension Road. Designed to offer a world-class shopping and dining experience, it features high-street retail shops, food courts, multiplexes, and modern amenities. Its strategic location, luxurious infrastructure, and strong footfall make it a prime investment destination in Gurugram's real estate market.


M3M Route 65
Commercial Space Gurgaon

Email id -- info@trueassetconsultancy.com
phone no. -- 8750007475

The market for Immuno Oncology Assay was valued at USD 7.84 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.87% by 2031.

The Oncology Clinical Trials Market is expected to reach USD 14.2 billion in 2023, with a compound annual growth rate (CAGR) of 6.2% forecast by 2031

ICMAI CMA Course 2026 Application has Started for June & December Exam. Check Application process, course fee, syllabus & More.

the market size of Drug Eluting Stent reached USD 7.9 billion, with a projected compound annual growth rate (CAGR) of 8.9% anticipated till 2031.